Back to top
more

The Ensign Group (ENSG)

(Delayed Data from NSDQ)

$117.74 USD

117.74
200,474

-0.60 (-0.51%)

Updated May 13, 2024 04:00 PM ET

After-Market: $117.91 +0.17 (0.14%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 2% (4 out of 251)

Industry: Medical - Nursing Homes

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why Ensign Group (ENSG) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Encompass Health (EHC) Q4 Earnings Beat on Higher Discharges

by Zacks Equity Research

Encompass Health's (EHC) Q4 results gain on improved net patient revenue per discharge and higher net income. Management estimates 2024 adjusted EPS to be $3.77-$4.06.

Ensign Group (ENSG) Q4 Earnings Beat, Stock Up 5%

by Zacks Equity Research

Ensign Group's (ENSG) fourth-quarter results were aided by improved same-store occupancy and an increase in rental revenues. Management expects 2024 adjusted EPS within $5.29-$5.47.

Ensign Group (ENSG) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Ensign Group (ENSG) delivered earnings and revenue surprises of 0.79% and 0.54%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Here's Why Ensign Group (ENSG) is a Strong Growth Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain Humana (HUM) in Your Portfolio

by Zacks Equity Research

Humana (HUM) remains well-poised for growth, attributable to an aging U.S. population, contract wins, acquisitions and expanding cash reserves.

Ensign (ENSG) Buys 2 Nursing Facilities in Tennessee & Nevada

by Zacks Equity Research

The acquisition deals have increased Ensign's (ENSG) portfolio to encompass 299 healthcare operations spanning 14 states.

Ensign Group (ENSG) Rises 23% in 3 Months: More Room to Run?

by Zacks Equity Research

Ensign Group (ENSG) remains well-poised for growth, courtesy of an extensive treatment network, higher rental revenues and uninterrupted dividend hikes.

Ensign Group (ENSG) Sanctions 4% Quarterly Dividend Hike

by Zacks Equity Research

Ensign Group (ENSG) announces a dividend hike, underlining a strong financial position and continued focus on deploying capital to shareholders.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Is Ensign Group (ENSG) Up 13.8% Since Last Earnings Report?

by Zacks Equity Research

Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Henry Schein (HSIC) Q3 Revenues Miss, 2023 Guidance Cut

by Zacks Equity Research

Henry Schein's (HSIC) third-quarter 2023 performance demonstrates remarkable sales growth in the Technology and Value-Added Service businesses.

National Vision (EYE) Q3 Earnings Top Estimates, Margins Fall

by Zacks Equity Research

National Vision's (EYE) higher SG&A expenses in the third quarter reflect increases in performance-based incentives and stock-based compensations.

Illumina (ILMN) Q3 Earnings Surpass Estimates, '23 View Cut

by Zacks Equity Research

Illumina (ILMN) reports solid earnings in the third quarter of 2023 amid a challenging macro environment.

Phibro (PAHC) Q1 Earnings and Revenues Miss, Margins Down

by Zacks Equity Research

Phibro's (PAHC) fiscal 2024 first-quarter performance reflects reduced sales in Mineral Nutrition and Performance Products.

STERIS (STE) Q2 Revenues Surpass Estimates, Margins Down

by Zacks Equity Research

STERIS' (STE) fiscal 2024 second-quarter results reflect continued momentum in the Healthcare business.

Bruker (BRKR) Q3 Earnings and Revenues Top, '23 Sales View Up

by Zacks Equity Research

Bruker (BRKR) delivers better-than-expected earnings and revenues in the third quarter of 2023.

Prestige Consumer (PBH) Q2 Revenues Top, Margins Expand

by Zacks Equity Research

Prestige Consumer's (PBH) second-quarter fiscal 2024 results benefit from a diverse brand portfolio and broad distribution.

Omnicell (OMCL) Q3 Earnings and Revenues Beat, Margins Down

by Zacks Equity Research

Omnicell's (OMCL) third-quarter 2023 results reflect operational discipline in a weak demand environment.